Aridis Pharmaceuticals Inc. - Common Stock (NQ:ARDS)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 18, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Aridis Pharmaceuticals Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

April 06, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

April 03, 2023

On Monday, 76 companies set new 52-week lows.

Via Benzinga

Why Aridis Pharmaceuticals Shares Are Diving ↗

March 14, 2023

Aridis Pharmaceuticals Inc (NASDAQ: ARDS) shares are trading lower by 23.34% to $0.42 Tuesday morning after the company announced a $2.28 million registered direct offering.

Via Benzinga

Why Aridis Pharmaceuticals Shares Are Soaring Today ↗

March 13, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

April 03, 2023

We're starting off the week with a breakdown of the biggest pre-market stock movers worth keeping an eye on Monday morning!

Via InvestorPlace

AstraZeneca Axes Pneumonia Drug Pact With Aridis ↗

March 29, 2023

AstraZeneca plc (NASDAQ: AZN) scrapped its license agreement with Aridis Pharmaceuticals Inc (NASDAQ: ARDS).

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

March 14, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

March 13, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

March 14, 2023

Tuesday's morning session saw 84 companies set new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

March 09, 2023

Via Benzinga

Why RAPT Therapeutics Shares Are Trading Lower By Over 30%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

March 14, 2023

Gainers Ainos, Inc. (NASDAQ: AIMD) shares jumped 69.3% to $1.27 after the company announced it signed a Memorandum of Understanding with Merdury Biopharmaceutical to jointly explore and develop a...

Via Benzinga

Interviews with Rail Vision, Aridis Pharmaceuticals, and Digital Ally to Air on Bloomberg U.S. on the RedChip Money Report(R)

February 17, 2023

Via ACCESSWIRE

Dow Surges Over 100 Points; World Acceptance Shares Spike Higher ↗

January 26, 2023

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining over 100 points on Thursday. The Dow traded up 0.35% to 33,863.38 while the NASDAQ rose 1.33% to 11,463.77. The S&P 500...

Via Benzinga

Why Bank Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

March 13, 2023

Gainers Provention Bio, Inc. (NASDAQ: PRVB) shares jumped 250.8% to $23.50 after Sanofi announced it will acquire the company for $25 per share in cash.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 26, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

February 28, 2023

During Tuesday, 79 stocks hit new 52-week lows.

Via Benzinga

US GDP Rises 2.9% In Q4; Crude Oil Up Over 1% ↗

January 26, 2023

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.27% to 33,834.44 while the...

Via Benzinga

Why Panbela Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

January 26, 2023

Gainers MicroAlgo Inc. (NASDAQ: MLGO) shares jumped 74% to $2.90. MicroAlgo recently entered into securities purchase agreement for up to $3.2 million.

Via Benzinga

Why eHealth Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket ↗

January 26, 2023

Gainers Minerva Surgical, Inc. (NASDAQ: UTRS) shares rose 66.2% to $0.6312 in pre-market trading after gaining 72% on Wednesday. Minerva Surgical recently announced a $30 million private placement of...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

January 26, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

January 26, 2023

We're starting off the day with an overview of the biggest pre-market stock movers that traders need to watch on Thursday!

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

January 25, 2023

Via Benzinga

Why eHealth Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket ↗

January 25, 2023

Gainers Inpixon (NASDAQ: INPX) shares rose 41% to $2.20 in pre-market trading after gaining 6% on Tuesday. Inpixon, last month, secured a purchase order valued at over $1m for its RTLS products from a...

Via Benzinga

Why Grom Social Enterprises Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

January 25, 2023

Gainers Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) shares surged 85% to $2.2200. Sonoma Pharmaceuticals and EMC Pharma announced Department of Defense DAPA registration for Microcyn(R) Rx products.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

January 25, 2023

It's time to start off the day with an overview of the biggest pre-market stock movers traders need to know about on Wednesday!

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

January 24, 2023

Via Benzinga

Why LogicMark Shares Are Trading Lower By Around 25%; Here Are 20 Stocks Moving Premarket ↗

January 24, 2023

Gainers Axcella Health Inc. (NASDAQ: AXLA) rose 71.7% to $0.7450 in pre-market trading after the company reported regulatory path to registration of AXA1125 for long COVID-19 fatigue.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

January 24, 2023

We're starting the day with a look at the biggest pre-market stock movers traders need to know about on Tuesday morning!

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

December 29, 2022

Via Benzinga

(Updated) Aridis Pharmaceuticals Receives Equity Investment from the Cystic Fibrosis Foundation

December 12, 2022

From Aridis Pharmaceuticals, Inc.

Via GlobeNewswire

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.